Simplex Trading
AUTL

Simplex Trading’s Autolus Therapeutics AUTL Stock Holding History

Simplex Trading’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101K Buy
72,900
+57,800
+383% +$87.8K ﹤0.01% 5082
2025
Q4 		$30K Sell
15,100
-12,000
-44% -$18.4K ﹤0.01% 6110
2025
Q3 		$44K Buy
27,100
+2,900
+12% +$5.67K ﹤0.01% 6581
2025
Q2 		$55K Sell
24,200
-13,200
-35% -$21.8K ﹤0.01% 5820
2025
Q1 		$57K Buy
37,400
+18,900
+102% +$38.4K ﹤0.01% 5622
2024
Q4 		$43K Buy
18,500
+16,600
+874% +$56.1K ﹤0.01% 6019
2024
Q3 		$6K Buy
+1,900
New +$7.58K ﹤0.01% 7484
2024
Q2 		– Sell
-2,500
Closed -$15K – 8741
2024
Q1 		$15K Sell
2,500
-300
-11% -$1.87K ﹤0.01% 7306
2023
Q4 		$18K Sell
2,800
-7,800
-74% -$29.7K ﹤0.01% 6984
2023
Q3 		$24K Sell
10,600
-6,000
-36% -$17.1K ﹤0.01% 6458
2023
Q2 		$39K Buy
16,600
+13,900
+515% +$33K ﹤0.01% 6066
2023
Q1 		$4K Sell
2,700
-47,600
-95% -$93.1K ﹤0.01% 8136
2022
Q4 		$95K Buy
50,300
+43,400
+629% +$110K ﹤0.01% 5142
2022
Q3 		$14K Buy
6,900
+4,100
+146% +$12.1K ﹤0.01% 7883
2022
Q2 		$7K Sell
2,800
-10,500
-79% -$32K ﹤0.01% 8547
2022
Q1 		$55K Sell
13,300
-8,000
-38% -$33.6K ﹤0.01% 6999
2021
Q4 		$110K Buy
+21,300
New +$128K ﹤0.01% 6095

Other funds holding AUTL

MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's AUTL Position: Q1 2026 in Review

Simplex Trading reduced its Autolus Therapeutics (AUTL) stake by 59% in Q1 2026, selling an estimated $52.1K and leaving 23,641 shares worth $32.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6302.

Simplex Trading first reported a position in AUTL in Q3 2023 and has held it in 10 quarters since. The position peaked at $115K in Q4 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Simplex Trading held 23,641 shares of Autolus Therapeutics worth $32.6K as of Q1 2026.
  • Simplex Trading sold 34,278 Autolus Therapeutics shares in Q1 2026, an estimated $52.1K.
  • Autolus Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6302 holding.
  • Simplex Trading first reported a position in Autolus Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • Simplex Trading's Autolus Therapeutics position peaked at $115K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.